Medicalgorithmics (WAR:MDG) LT-Debt-to-Total-Asset: 0.17 (As of Mar. 2026)

What is Medicalgorithmics LT-Debt-to-Total-Asset?

Medicalgorithmics WAR:MDG +2.59% 70 LT-Debt-to-Total-Asset is 0.17 as of Mar. 2026. GuruFocus rates WAR:MDG with a GF Score™ of 70/100 and a GF Value™ of zł27.01 (Fairly Valued). The stock has 4 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Medicalgorithmics's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.17.

Medicalgorithmics's long-term debt to total assets ratio increased from Mar. 2025 (0.05) to Mar. 2026 (0.17). It may suggest that Medicalgorithmics is progressively becoming more dependent on debt to grow their business.

Medicalgorithmics (WAR:MDG) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Medicalgorithmics LT-Debt-to-Total-Asset Related Terms

Medicalgorithmics LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Medicalgorithmics's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicalgorithmics LT-Debt-to-Total-Asset Chart

Medicalgorithmics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.07

0.00

0.03

0.16

Medicalgorithmics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.05	0.11	0.15	0.16	0.17

70GF Score

Medicalgorithmics SA WAR:MDG

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Medicalgorithmics LT-Debt-to-Total-Asset Calculation

Medicalgorithmics's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )	/	Total Assets (A: Dec. 2025 )
	=	17.22	/	108.233
	=	0.16

Medicalgorithmics's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )	/	Total Assets (Q: Mar. 2026 )
	=	18.561	/	111.359
	=	0.17

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.17 mean?

Medicalgorithmics (WAR:MDG) has a LT-Debt-to-Total-Asset of 0.17 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Medicalgorithmics and its competitors.

Is Medicalgorithmics' LT-Debt-to-Total-Asset too high?

Medicalgorithmics' current LT-Debt-to-Total-Asset is 0.17. Overall, Medicalgorithmics has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Medicalgorithmics' LT-Debt-to-Total-Asset compare to ABT and SYK?

Medicalgorithmics' LT-Debt-to-Total-Asset of 0.17 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?

A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Medicalgorithmics and its competitors. Medicalgorithmics's current LT-Debt-to-Total-Asset is 0.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Medicalgorithmics stock overvalued right now?

Based on GuruFocus' analysis, Medicalgorithmics (WAR:MDG) is currently considered Fairly Valued. The stock's GF Value™ is zł27.01, compared to a current price of zł27.70 — trading 2.6% above its estimated fair value. The current LT-Debt-to-Total-Asset is 0.17. Medicalgorithmics' overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Medicalgorithmics (WAR:MDG), the current LT-Debt-to-Total-Asset is 0.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicalgorithmics (WAR:MDG) Overvalued in 2026?

Based on GuruFocus' analysis, Medicalgorithmics stock appears to be overvalued. The current stock price of zł27.70 is trading 2.6% above its estimated GF Value™ of zł27.01. GuruFocus considers Medicalgorithmics to be Fairly Valued.

Key valuation signals for WAR:MDG:

LT-Debt-to-Total-Asset: 0.17
GF Value™: zł27.01 vs. price of zł27.70 (2.6% above fair value)
GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the WAR:MDG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medicalgorithmics Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies WAR:GMT WAR:AME WAR:MTN WAR:NST WAR:GMZ WAR:SDS WAR:INM WAR:MSM WAR:CMI WAR:ADV ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Address Al Jerozolimskie 81, 19 Floor, Central Tower Building, Warsaw, POL, 02-001

Website http://www.medicalgorithmics.com

Medicalgorithmics SA is a medical technology company. It is engaged in the development of Digital Signal Processing (DSP) algorithms development and software and hardware electronics design for medical applications. The company specializes in providing advance technological solutions in the field of cardiac diagnostics, with a particular focus on ECG signal analysis. The group concentrates on the production and development of its flagship product Pocket ECG - a system for remote monitoring of cardiac arrhythmias. The offered solutions include algorithms and diagnostic systems used in remote heart monitoring. The company operates in Poland, the USA, and other, with majority of revenue from the USA.

70GF Score

Get the complete analysis for WAR:MDG

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł27.70

Price

zł27.01

GF Value

View WAR:MDG Analysis

See LT-Debt-to-Total-Asset data for all stocks →